GranuLab (M) Sdn. Bhd. (formerly known as Supreme Headline Sdn. Bhd.) was established in May 2005 and is a subsidiary of Sindora Berhad (Member of Johor Corporation).
GranuLab has been granted by SIRIM Berhad the sole licensing to commercialise GranuMas™, a granular synthetic bone graft material and has embarked upon the setting up of medical grade plant for the production of GranuMas™.
Vide Technical Licensing Agreement with SIRIM Berhad, GranuMaS™ shall be produced in a medical grade certified production lab located in Technology Park Malaysia. The RM7.0 million facility shall be managed by a specifically trained and certified workforce to produce and commercialise GranuMaS™.
Mission
To establish the nation first medical grade production plant for synthetic bone graft.
Vision
To promote Malaysia as a centre for healthcare biotechnology through research and development, innovation and commercialisation.
www.granulab.com